Healthcare - Biotechnology - NASDAQ - US
$ 0.7551
-4.48 %
$ 90.2 M
Market Cap
-0.42
P/E
INCOME STATEMENT
0
REVENUE
-208 M
OPERATING INCOME
-199 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Invivyd, Inc.
| Revenue | 0 |
| Cost Of Revenue | 2.03 M |
| Gross Profit | -2.03 M |
| Operating Expenses | 206 M |
| Operating Income | -208 M |
| Other Expenses | -9.14 M |
| Net Income | -199 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | |
|---|---|---|---|---|
| REVENUE | ||||
| Revenue | 0 | 0 | 0 | 0 |
| GROSS PROFIT | ||||
| Cost Of Revenue | 2.0 | 0.5 | 1 K | 0 |
| Gross Profit | (2.0) | (0.5) | 1 K | 0 |
| OPERATING INCOME | ||||
| Operating Expenses | 205.8 | 226.3 | 219.4 | 65.3 |
| Selling, General and Administrative Expenses | 49.1 | 47.0 | 36.5 | 3.2 |
| Research and Development Expenses | 158.7 | 179.2 | 182.9 | 62.1 |
| Operating Income | (207.8) | (248.0) | (226.9) | (65.3) |
| PRE-TAX INCOME | ||||
| Interest Income Expense | 0 | 43.1 | 0 | 0 |
| Total Other Income | 9.1 | 6.7 | (7.4) | 8 K |
| Pre-Tax Income | (198.6) | (241.3) | (226.8) | (65.3) |
| NET INCOME | ||||
| Tax Provision | 0 | (6.7) | 7.5 | 43.2 K |
| Net Income | (198.6) | (234.6) | (234.3) | (65.3) |
| EPS | 1.81 | 2.17 | 2.11 | 0.59 |